{"version":"1.0","type":"link","title":"Phase 1 Trial of  Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials.","author_name":"Heo JU 외","author_url":"https://prs-insight.online/author/Heo%20JU","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99101","thumbnail_width":1200,"thumbnail_height":630}